26 – 27 febrero, 2026, Guadalajara, México

International Summit on Cellular & Immune Therapies - Translational Science and Evidence in Practice

Clear evidence for responsible access.…

To put it simply

Purpose of the event

Bring together clinical, academic, industry, and public-sector stakeholders to separate evidence from noise, clarify regulatory pathways, and accelerate responsible adoption of cell therapies, immunotherapies, and orthobiologics across Mexico and LATAM.

By the end, you will gain:
– Actionable criteria to distinguish robust evidence from unsupported claims.
– Clinical implementation protocols and checklists for monitoring.
– Roadmaps for responsible access and compliance.
– Connections for trials, pilots, and technology transfer.

Scope

Thematic Tracks

– Current clinical evidence on MSCs, NK cells, exosomes, and orthobiologics.
– Protocol and endpoint design: efficacy, safety, and clinical value.
– Manufacturing and quality: from lab to GMP; traceability and release.
– Regulatory pathways and ethics: best practices and off-label use.
– Clinical implementation and technovigilance: from trial to hospital practice.
– Real-world cases: lessons in success, boundaries, and risks.

Preventa

First glance

Preliminary Program

An English/Spanish translator will be available

Day 1

Thursday 26 Feb, 2026

Theme:
Immune Modulation, Clinical Evidence & Regulatory Responsibility

10:00 – 10:30 am

Registration and Welcome

Organizing Committee

10:30-11:00 am

Official Opening (Cuadruple Helix)

Representatives from the Federal Government, the Cluster, Industry, and Academia

11:00 – 12:00 am

NK Cells and Modern Immunotherapy

Speaker:
Jeffrey Miller, MD, PhD

12:00 – 12:30 am

Coffee Break

Networking 30 min

12:30 – 13:30

Small Mobile Stem Cells (SMS): Clinical Promise

Speaker:
Abdulkader Rahmo, PhD

13:30 – 15:00 am

Lunch

15:00 – 15:30

Manufacturing & Good Practices in Mexico

Speaker:
Engr. Selem Torres

15:30 – 16:00 am

Clinical Case: Regenerative Orthopedics

Speaker:
Dr. José Luis Carrillo Gamboa

16:00 – 16:30

Clinical Case:
Personalized MSC Immunomodulation

Speaker:
Dr. Abraham Ortiz F.

16:30 – 17:00 am

Coffee Break

Networking 30 minutos

17:00 – 17:45

Featured Clinical Spotlight — Regulatory T Cells in Clinical Immunoregulation

Speaker:
Dr. Gloria Soldevila

17:45 – 18:45

Regulatory & Ethics Roundtable — LATAM Pathways to Safe Innovation

Moderator: Dr. Juan Pablo Aguilar Alemán
Panelistas: Dra. Lilia C. León · Dr. Jorge M. Tagle Rodríguez · Dra. Sonia M. Pérez T. – Dr. José A. Miranda N. – Dr. Luis A. Tabe G.

Day 2

Friday 27 Feb, 2026

Theme:
Strong Clinical Outcomes & the Future Beyond the Hype

10:00- 10:30

Welcome Coffee

Organizing Committee

10:30 – 11:30

The Future Beyond CAR-T

Speaker:
Prof. Alejandro Madrigal, OBE, MD, PhD, FRCP, FRCPath, DSc,
HonDSc, FMedSci; SNI Emeritus

11:30 – 12:30

ATMPs & GMP Regulation in Europe

Speaker:
Dr. Joaquím Vives

12:30 – 13:00

Coffee Break

Networking 30 min

13:00 – 14:00

Exosome Delivery Systems: Clinical Applications & Pitfalls


Speaker:
Bruna Corradetti, PhD, MSc

14:00 – 15:30

Lunch


15:30 – 16:15

Why Advanced Therapies Require True GMP — and How China Scaled It ?

Speaker: Dr. Nandini Prabhakar

16:15 – 16:45

Featured Clinical Spotlight — MSCs in GvHD: Clinical Evolution

Speaker:
Dr. Josué Eduardo Fernández –
The One Clinic by ITC

16:45- 17:15

Coffee Break

Networking 30 minutes

17:15 – 17:45

Clinical Case:
Pain Management with MSCs

Speaker:
Dr. Paulo Axel Téllez Reyes

17:45 – 18:45

Strategic Debate — Science vs Hype in Advanced Therapies (Debate+Q&A)

Moderator: Dr. Juan Pablo Aguilar Alemán
Panelists: Miller · Rahmo · Madrigal · Vives · Corradetti

18:45 – 19:00

Official Closing

Organizing Committee

21:00 – 01:00

Closing Reception — Premium Venue
(VIP Networking)

Our Speakers

Transparency, Compliance, and Ethics

Best practices: Adherence to ethics, biosafety, and data protection.

Jeffrey S. Miller

MD, Interim Director; Co-Leader Immunology Program

Abdulkader Rahmo, PhD

Co-Founder, President, CSO of SMSbiotech

Bruna Corradetti, PhD

Baylor College of Medicine, Houston, Texas, USA

Alejandro Madrigal

Professor in Hematology
and Cellular Therapy

Joaquím Vives, PhD

Blood and
Tissue Bank of Barcelona (Banc de
Sang i Teixits)

Dra. Lilia León

Cell Therapy Liaison | Translational Research | CMC, QA & Regulatory Strategy | Advancing Evidence-Based Therapies in LATAM

Dra. Gloria Soldevila M.

Investigadora Titular del Departamento de Inmunología del Instituto de Investigaciones Biomédicas UNAM

Dr. José Luis Carrillo G.

Fundador y Director de la Clínica de Ortopedia y Rehabilitación CORE Regenera QRO. Investigador en la ULS y la UVM, conferencista en el campo de la ortopedia y la medicina regenerativa.

Dra. Sonia Mayra Pérez T.

Profesor-investigador titular “C” en el Departamento de Inmunología de la Escuela Nacional de Ciencias Biológicas (ENCB) del Instituto Politécnico Nacional (IPN) y profesor de Inmunología de la Facultad de Química de la UNAM.

Dr. Nandini Prabhakar

Biochemist/
Immunologist by training and a biotechnology leader with over 20 years of international experience spanning academia and industry in advanced cell culture, bioprocess development, and large-scale manufacturing.

Dr. José Arturo Miranda Nava

Máster en Medicina Regenerativa y Terapia celular.
Medalla Héroes de la Patria. FCAP. 2022-2025.
Premio RECELL . 2023.
Doctoratum Honoratum. 2023-2024.
Galardón al Mérito Médico. 2024.
MEDALLA THERMIS. UNAM . 2025

Dr. Abraham Ortiz Fajardo

-Postgrado en Medicina Regenerativa en el IESBM.
-Certificado en Ozonoterapia por el CMNBM
– Miembro fundador de la Sociedad Médica de Ozonoterapia de México.
– Docente de postgrado en el IESBM.
– Miembro del Colegio Mexicano de Medicina Regenerativa y Redox
– Miembro del Colegio Mexicano de Células Madre y Medicina Regenerativa A.C.

Introduction

About Organizing Committee

The event is organized by an independent committee composed of clinical, academic, and industry leaders, with strategic alliances that promote the articulation of the quadruple helix (government–industry–academia–clinical). Its mission is to separate evidence from noise and accelerate the responsible adoption of cell therapies, immunotherapies, and orthobiologics in Mexico and LATAM, under the motto “Clear evidence for responsible access.” Participation by public sector representatives, when it occurs, will be technical and informative, without implying institutional commitments.

The Committee operates with transparency (conflict of interest disclosures and off-label flagging), ethical adherence, and a focus on reproducible protocols, clinical endpoints, and technovigilance.

Strict Standards, Evidence, and Academic Endorsement
Backed by UAG – School of Medicine.

Complete the program and receive a certificate with curricular value, issued under the endorsement of UAG – School of Medicine.

Join in and take the lead…!

Universidad Autónoma de Guadalajara

UAG- Auditorio Luis Garibay

Av. Patria 1201, Lomas del Valle, 45129 Zapopan, Jal.
Ph: +52-331-553-9774

Preventa

- The Trusted Support Behind Our Mission

Our Strategic Allies

Shopping Cart